id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-0008-0004,FDA,FDA-2026-N-0008,Advisory Committee; Blood Products Advisory Committee; Renewal,Notice,Notice of Renewal,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T17:02:15Z,2026-09108,0,0,09000064b92c85a3
FDA-2026-N-0008-0003,FDA,FDA-2026-N-0008,Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal,Notice,Notice of Renewal,2026-04-30T04:00:00Z,2026,4,,,2026-04-30T18:03:08Z,2026-08378,0,0,09000064b92b7f20
FDA-2026-N-0008-0002,FDA,FDA-2026-N-0008,"Advisory Committee; Obstetrics, Reproductive and Urologic Drugs Advisory Committee; Renewal",Notice,Notice of Renewal,2026-03-18T04:00:00Z,2026,3,2026-03-18T04:00:00Z,,2026-03-18T17:48:29Z,2026-05313,0,0,09000064b9221514
FDA-2026-N-0008-0001,FDA,FDA-2026-N-0008,Advisory Committee; Gastrointestinal Drugs Advisory Committee; Renewal,Notice,Notice of Renewal,2026-02-24T05:00:00Z,2026,2,2026-02-24T05:00:00Z,,2026-02-24T20:00:59Z,2026-03587,0,0,09000064b91d5691